Illumina will customize a gene chip to find mutations from this minority group.

A Johns Hopkins-led team of scientists is conducting a four-year program to map the genetic code of 1,000 people of African descent. The National Heart, Lung and Blood Institute has provided the team with $9.5 million in study funding.

Researchers say their initial goal is to find genetic variations underlying asthma and to explain why the disease disproportionately afflicts blacks. As much as 20% of African-Americans reportedly have asthma.

Study principal investigator and immunogeneticist Kathleen Barnes, Ph.D., says the effort to sequence the genetic code of 500 asthmatics and 500 nonasthmatics “represents an exciting opportunity to disentangle the genetic basis of a host of other diseases, not just asthma, which have a hereditary component and uniquely or disproportionately affect minorities.”

For part of the initiative, the researchers have contracted with Illumina to create a commercially available, customized gene chip, or DNA microarray test, dubbed the “African power chip,” to quickly find single mutations in genetic materials from blacks that may be associated with heightened disease risk.

Dr. Barnes, a professor in the division of allergy and clinical immunology at the Johns Hopkins University School of Medicine and the university’s Bloomberg School of Public Health, and her team say they will make their findings freely available to other researchers through the dbGAP national database of genome-wide association studies, maintained by the National Library of Medicine.

Dr. Barnes says her team’s findings should fill in serious gaps in the hunt for genetic variations posed by Illumina’s existing genotyping chip and a similar gene chip by Affymetrix. Both chips were developed from whole genome sequencing of predominantly white European men and women and do not represent potential variations found mostly or only in minority groups.

“One of our biggest barriers as researchers trying to find the underlying genetic roots of disease in minority groups has been the persistent lack of microarray testing tools relevant to each racial profile, especially African-Americans,” says Dr. Barnes, director of Johns Hopkins’ Genetics Research Facility and its Lowe Family Genomics Core laboratory.

“Asthma is exacerbated by social factors such as poverty and inadequate education and access to medical care,” adds Barnes, “so separating out the genetic component is particularly complex but scientifically doable.”

Researchers plan to sequence the genomes of blacks selected from among an international group of people participating in existing genetic studies, who have already been clinically diagnosed with asthma, or without, or who have other kinds of compromised lung function and whose family histories are well documented. The participants will be selected from 15 academic research centers across the U.S., the Caribbean, and South America, as well as from four additional research sites in Western Africa.

Previous articleAMT Raises €2.5M but Says Future Still Hangs in the Balance
Next articlePoll Respondents Mostly Confident U.S. Can Protect Second-Opinion Genetic Test Developers